Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

Milestone Scientific posts strong Q2 demand growth; expanding federal distribution

Aug 14, 2026, 7:37 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strong YoY growth in medical segment, payer coverage progress, and a new federal distribution channel could unlock higher earnings power. The non-recurring international orders in Q2 pose a near-term caveat, but the reaffirmed 2026 outlook and faster CompuFlo growth underpin upside potential.

AI summary

What happened, with direct paths to the underlying reporting

Milestone Scientific reported Q2 2026 revenue of $2.8 million, up 22% YoY, with CompuFlo medical sales surging 230%. The company reaffirmed 2026 guidance and highlighted Medicare reimbursement around $325 per CompuFlo procedure, plus a strategic distribution deal with Red One Medical covering VA/DoD programs and broader international expansion. These catalysts support improved cash flow prospects toward breakeven in early 2027.

Q2 2026 revenue $2.8M; up 22% YoY.
Six-month revenue $5.0M; up 10% YoY.
CompuFlo revenue up 230% YoY; Medicare reimbursement in place.
Strategic distribution with Red One Medical to VA/DoD; international expansion.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.